Emjard M 5mg/500mg (14 Tablet / Pack)
Prescription low-dose combination antidiabetic tablet for type 2 diabetes.
Emjard M 5mg/500mg Tablets are a prescription-only combination oral antidiabetic medication indicated for adults with type 2 diabetes mellitus. This lower-dose pairing allows for customized metabolic titration to minimize initial gastrointestinal side effects. It lowers overall plasma glucose levels by slowing liver glucose release, reducing intestinal sugar intake, and clearing excess sugar via urine.
Purpose
Used to manage blood glucose levels via dual renal and metabolic pathways.
Ingredients
Empagliflozin 5mg, Metformin HCl 500mg
Warnings
Risk of serious volume depletion and sudden drop in blood pressure. Contraindicated in cases of advanced metabolic acidosis or diabetic coma. Do not introduce if the baseline glomerular filtration rate is severely compromised. Inform your doctor if you develop signs of an active urinary infection.
Side Effects
Mild nausea or indigestion Elevated frequency of micturition Genital area itching or infection Temporary vitamin B12 reduction
Storage Instructions
Store at room temperature below 30°C away from direct sunlight.
| Status | Active |